col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


113 Results       Page 1

 [1] 
Mary Ann Liebert: Viral Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―13 Clinical Evaluation of the Accuracy of the Panbio™ COVID-19/Flu A&B Rapid Panel: A Combination Antigen Rapid Diagnostic Test for the Omicron Variant and Influenza A Virus Hirokazu Yamagishi, Daisuke Tamura, Masahiko Yamazaki, Takashi Abe, Keiko Mitamura, Toshihiro Tajima, Hitoshi Osaka
2 [GO] 2024―Jul―05 Noncoding RNAs in the COVID-19 Saga: An Untold Story Mudasir Maqbool, Md Sadique Hussain, Nusrat K. Shaikh, Ayesha Sultana, Ajay Singh Bisht, Mohit Agrawal
3 [GO] 2024―Jun―06 Association of Interleukin-6 (rs1800795) and Interleukin-10 (rs1800896) Genetic Polymorphisms with the Outcome of COVID-19 Infection: A Single Center Study Mahmoud El-Bendary, Mustafa Naemattalah, Hatem Elalfy, Ahmed Elhawary, Abdel-Hady El-Gilany, Hosam Zaghloul, et al. (+2)
4 [GO] 2024―May―08 Bioinformation Analysis of Differential Expression Proteins in Different Processes of COVID-19 Nana Guo, Xu Han, Guangyue Han, Mingyan Dai, Zhanying Han, Qi Li
5 [GO] 2024―May―08 Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population Sara M. Elessawy, Abeer Shehab, Dina A. Soliman, Mai A. Eldeeb, Sara I. Taha
6 [GO] 2024―Mar―18 Research Progress on the Weak Immune Response to the COVID-19 Vaccine in Patients with Type 2 Diabetes Shiqi Yuan, Wenwen He, Bin Liu, Zhuoran Liu
7 [GO] 2024―Feb―05 Role of the SARS-CoV-2 Virus in Brain Cells Ali Azargoonjahromi
8 [GO] 2024―Jan―25 Interaction Between Genetic Susceptibility and COVID-19 Pathogenesis in Pediatric Multisystem Inflammatory Disorders: The Role of Immune Responses Li-Na Chen, Zhang-Xuan Shou, Xue Jin
9 [GO] 2023―Nov―29 Relationship Between Human FCγRIIA rs1801274 G Allele and Risk of Death Among Different SARS-CoV-2 Variants Nazanin Moghaddam, Mohammad Taghi Goodarzi, Sina Moghaddam, Fatemeh Sakhaee, Iraj Ahmadi, Enayat Anvari, Abolfazl Fateh
10 [GO] 2023―Nov―14 Continuing to Learn About COVID-19 Rodney S. Russell
11 [GO] 2023―Oct―13 Expression Pattern of Cholesterol 25-Hydroxylase and Serum Level of 25-Hydroxycholesterol and Relevant Inflammatory Cytokines in Patients with Varying Disease Severity of COVID-19 Mona Roozbehani, Mohammad Hossein Razizadeh, Hossein Keyvani, Fatemeh Nejati, Sharareh Soleymani, Leila Mousavizadeh
12 [GO] 2023―Oct―13 Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela Mahmoud M. Bahgat, Rola Nadeem, Mohamed H. Nasraa, Khaled Amer, Wael A. Hassan, Fadya M. ELGarhy, et al. (+2)
13 [GO] 2023―Oct―05 Immunosenescence and Inflammaging in COVID-19 Faezeh Asghari, Amir Asghary, Naime Majidi Zolbanin, Fatemeh Faraji, Reza Jafari
14 [GO] 2023―Oct―02 Potent Antibody Response Elicited by a Third Booster Dose of Inactivated COVID-19 Vaccine in Healthy Subjects Ruili Ji, Jiaqi Zhang, Dan Liang, Hongbing Quan, Yue Wu, Aiping Peng, et al. (+6)
15 [GO] 2023―Sep―05 Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination Taoyuan Li, Shaorong Wu, Jiaxiong Tan, Zhengyi Huang, Lijun Li, Wenzhi Luo, et al. (+3)
16 [GO] 2023―Aug―29 Development of ELISA-Based Assay for Detection of SARS-CoV-2 Neutralizing Antibody K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Somnath Singh
17 [GO] 2023―Aug―25 Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice Shuang Bai, Yanli Kang, Weixin Chen, Hui Xie, Lichi Zhang, Min Lv, et al. (+3)
18 [GO] 2023―Aug―21 Elevated Levels of Cytotoxicity, Cytokines, and Anti-SARS-CoV-2 Antibodies in Mild Cases of COVID-19 Miguel A. Fernández-Rojas, Guillermina Ávila, Mirza Romero-Valdovinos, Tanya Plett-Torres, Ana María Salazar, Monserrat Sordo, et al. (+9)
19 [GO] 2023―Jul―28 Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, Maryam Hafizi, Hamidreza Jamaati, Seyed Mehdi Hassanzadeh, et al. (+3)
20 [GO] 2023―Jun―05 Longitudinal Observation of Immune Response for 23 Months in COVID-19 Convalescent Patients After Infection and Vaccination Jingru Xu, Juan Zheng, Yan Tan, Jiaojiao Cai, Yao Xiang, Hua Ling, et al. (+2)
21 [GO] 2023―Jun―05 Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review Elham Jamali, Shima Shapoori, Majid Reza Farrokhi, Sina Vakili, Davoud Rostamzadeh, Farideh Iravanpour, et al. (+2)
22 [GO] 2023―May―19 Comparison of Achievements in the Implementation of COVID-19 Vaccination in Five Provinces to Establish Herd Immunity in Indonesia in the Perspective of the New Public Service Dyah Mutiarin
23 [GO] 2023―May―15 Correction to: A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection, by Kim, et al. Viral Immunology 2023;36(3):203-208; doi: 10.1089/vim.2022.0133.
24 [GO] 2023―May―04 Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Second and Third Doses, and Influence on Immunovirological Markers Francesco M. Fusco, Maria Aurora Carleo, Nadia Sangiovanni, Maurizio D'Abbraccio, Orsola Tambaro, Francesco Borrelli, et al. (+12)
25 [GO] 2023―May―04 Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals Marco Fabiani, Katia Margiotti, Francesca Monaco, Antonella Viola, Antonella Cima, Alvaro Mesoraca, Claudio Giorlandino
26 [GO] 2023―Mar―31 Re: “Association of the Interleukin 1B-31*C Proinflammatory Allele with the Severity of COVID-19 Patients: A Preliminary Report” by Galán-Huerta et al. Amnuay Kleebayoon, Viroj Wiwanitkit
27 [GO] 2023―Mar―24 Assessment of Proinflammatory Cytokines Among Patients with Middle East Respiratory Syndrome Coronavirus Infection Abdulkarim F. Alhetheel, Ahmed M. Albarrag, Zahid A. Shakoor, Ali M. Somily, Mazin A. Barry, Haifa Altalhi, et al. (+6)
28 [GO] 2023―Mar―23 A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection Heui Man Kim, Eun Ju Lee, Sang Won O, Yong Jun Choi, Hyeokjin Lee, Sae Jin Oh, et al. (+11)
29 [GO] 2023―Mar―10 Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India Poonam Suryawanshi, Bhagyashri Takbhate, Prachi Athavale, Priyanka Jali, Nilam Memane, Shahzad Mirza, et al. (+11)
30 [GO] 2023―Feb―27 Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients Hala Gabr, Asmaa A. Abdel _Aal, Samah Bastawy, Mohamed Fateen, Omnia Y. Abd El Dayem, Eman A. Youssef, et al. (+2)
31 [GO] 2023―Feb―24 Asymptomatic COVID-19 Reinfection in a Pediatric Patient with Heterotaxy Syndrome Guliz Erdem, Clifford L. Cua, Amrita Basu, Simon Lee, Amy Leber, Roshini S. Abraham
32 [GO] 2023―Feb―17 Association of the Interleukin 1B-31*C Proinflammatory Allele with the Severity of COVID-19 Patients: A Preliminary Report Kame Alberto Galán-Huerta, Myriam Aseret Zamora-Márquez, Rómulo Omar Flores-Pérez, Paola Bocanegra-Ibarias, Daniel Salas-Treviño, Ana María Guadalupe Rivas-Estilla, et al. (+8)
33 [GO] 2023―Feb―16 SARS-CoV-2 Variant-Specific mRNA Vaccine: Pros and Cons Shahla Shahsavandi, Amir Ali Hariri
34 [GO] 2023―Feb―03 Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors Yadira Lobaina, Rong Chen, Panchao Ai, Liling Yang, Liz Alvarez-Lajonchere, Edith Suzarte, et al. (+6)
35 [GO] 2023―Jan―17 D614G SARS-CoV-2 Pseudovirus Infectivity and Binding of Spike Protein to the ACE2 Receptor Inversely Correlates with Serum SARS-CoV-2-Specific IgG Levels Laura McCullagh, Noreen Sheehy, Cillian F. De Gascun, Jaythoon Hassan
36 [GO] 2023―Jan―10 Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants Faiqa Noor, Rabia Nawaz, Ammara Ahad, Anum Ajmal, Samyyia Abrar, Muhammad Shahid, et al. (+4)
37 [GO] 2022―Dec―19 Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children Gulhadiye Avcu, Sema Yildirim Arslan, Mehmet Soylu, Nimet Melis Bilen, Zumrut Sahbudak Bal, Candan Cicek, et al. (+2)
38 [GO] 2022―Dec―19 Detection of Middle East Respiratory Syndrome Coronavirus-Specific RNA and Anti-MERS-Receptor-Binding Domain Antibodies in Camel Milk from Different Regions of Saudi Arabia Aiydh Alshehri, Naiman Ali Mir, Nabil Miled
39 [GO] 2022―Dec―19 Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses Melika Haghighi, Akbar Khorasani, Pegah Karimi, Rouhollah Keshavarz, Mehdi Mahdavi
40 [GO] 2022―Nov―30 New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients Gulden Baskol, Merve Ozel, Hatice Saracoglu, Birkan Ulger, Gamze Kalin Unuvar, Sevda Onuk, et al. (+5)
41 [GO] 2022―Nov―07 Red Blood Cell Malfunction in COVID-19: Molecular Mechanisms and Therapeutic Targets Charalampos Papadopoulos, Eleftheria Spourita, Ioannis Tentes, Paschalis Steiropoulos, Konstantinos Anagnostopoulos
42 [GO] 2022―Oct―06 Antibody Therapy for COVID-19: Categories, Pros, and Cons Hadi Zare Marzouni, Marjan Rahbar, Nazanin Seddighi, Mohsen Nabizadeh, Sepideh Meidaninikjeh, Nasim Sabouni
43 [GO] 2022―Oct―03 Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors Supinya Phakaratsakul, Suwimon Manopwisedjaroen, Chompunuch Boonarkart, Pawinee Kupatawintu, Dootchai Chaiwanichsiri, Thaneeya Roytrakul, et al. (+2)
44 [GO] 2022―Sep―30 ACE2 Affects the Expression and Function of IFITM3 During SARS-CoV-2 Pseudovirus Infection in Vero E6 Cells Shunhua Long, Shenglong Li, Xiuzhen Zhang, Qiling Peng, Shuaizhi Chen, Jianwei Wang
45 [GO] 2022―Sep―13 Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, NLRP3, and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Severe/Critical COVID-19 Definitions Maedeh Radandish, Nafiseh Esmaeil, Farzin Khorvash, Alireza Andalib
46 [GO] 2022―Aug―23 Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity Majid Khoshmirsafa, Mohammad-Ali Assarehzadegan, Morteza Fallahpour, Maryam Azimi, Fatemeh Faraji, Taghi Riahi, et al. (+4)
47 [GO] 2022―Aug―11 Detection of the Serum Cytokines Predicts COVID-19 Pathogenesis in Egyptian Patients Lamiaa Mobarak, Mohamed Shemis, Raghda Samir Abdellatif, Amina Fouad, Mostafa H. Elberry, Reham M. Dawood
48 [GO] 2022―Aug―05 The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients Eman Z. Kandeel, Lobna Refaat, Ahmed Bayoumi, Hend A. Nooh, Reham Hammad, Medhat Khafagy, Mona S. Abdellateif
49 [GO] 2022―Aug―03 Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Rodney S. Russell
50 [GO] 2022―Jul―20 Response to Sriwijitalai and Wiwanitkit re “Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T and COVID-19: A Correspondence” Amirmasoud Rayati Damavandi, Farshid Fathi, Nahid Eskandari
51 [GO] 2022―Jul―20 Re: “Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T and COVID-19: A Correspondence” by Rayati Damavandi et al. Won Sriwijitalai, Viroj Wiwanitkit
52 [GO] 2022―Jul―20 SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination Tom Moore, Rojony Hossain, Katie J. Doores, Manu Shankar-Hari, David J. Fear
53 [GO] 2022―Jun―29 SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections Sepideh Meidaninikjeh, Nasim Sabouni, Mahdie Taheri, Mahdis Borjkhani, Sajad Bengar, Naime Majidi Zolbanin, et al. (+2)
54 [GO] 2022―May―17 Letter to the Editor: The Clinical Features of SARS-CoV-2 Infection Are Becoming Milder with Limited Symptomatic Effects Katia Margiotti, Marco Fabiani, Alvaro Mesoraca, Claudio Giorlandino
55 [GO] 2022―May―05 The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study Amirmasoud Rayati Damavandi, Parnian Zolfaghari Baghbadorani, Bahareh Kardideh, Hamed Fouladseresht, Marjan Golabi, Behrooz Ghezelbash, et al. (+4)
56 [GO] 2022―Apr―21 The Role of Immune Regulatory Molecules in COVID-19 Zahra Khalifehzadeh-Esfahani, Soheila Fattahi, Zahra Heidari Haratemeh, Morteza Jafarinia
57 [GO] 2022―Apr―01 The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis Eren Cagan, Gulcin Tezcan, Abdurrahman Simsek, Muhammed Ali Kizmaz, Fatma Dombaz, Ali Asan, et al. (+8)
58 [GO] 2022―Mar―25 Clinical Characteristics of COVID-19 Patients' Postvaccination Xiao-Bin Zhang, Si-Jiu Yang, Yong Lin, Li-Li Chen, Ya-Li Zhuang, Hui-Qing Zeng
59 [GO] 2022―Mar―24 Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Lilly Ganju, Rajeev Varshney
60 [GO] 2022―Mar―15 Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2 Akane Takamatsu, Satoshi Oshiro, Naeko Mizutani, Tatsuya Tada, Yoko Tabe, Takashi Miida, et al. (+2)
61 [GO] 2022―Mar―14 Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19 Maggie L. Bartlett, San Suwanmanee, Nadine Peart Akindele, Shristi Ghimire, Andy K.P. Chan, Chenxu Guo, et al. (+3)
62 [GO] 2022―Feb―23 Reduced Monocyte Subsets, Their HLA-DR Expressions, and Relations to Acute Phase Reactants in Severe COVID-19 Cases Ahmet Cizmecioglu, Ayca Emsen, Sua Sumer, Dilek Ergun, Hilal Akay Cizmecioglu, Hatice Turk Dagi, Hasibe Artac
63 [GO] 2022―Feb―15 Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients Hafsa Aziz, Shazia Fatima, Humera Mahmood, Shahkhalid Muhammad, Mohammad Adnan Saeed, Shaista Khurshid, et al. (+3)
64 [GO] 2022―Feb―15 Assessment of S-Specific IgG and IgM Positive Rates in Healthy Hospital Staff Members Vaccinated with the Inactivated SARS-CoV-2 Vaccine Lijun Zhou, Dabin Liu, Huihua Zhang, Limei Wu, Xuehui Liu, Xiaoyan Wang, et al. (+4)
65 [GO] 2022―Feb―10 Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study Maksim Koryukov, Andrey Kechin, Darya Shamovskaya, Anna Timofeeva, Maxim Filipenko
66 [GO] 2022―Feb―09 Occurrence and Associated Risk Factors of Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus Type 2 Infections in Greece Vasileios G. Papatsiros, Georgios Papakonstantinou, Eletherios Meletis, Nikolaos Tsekouras, Giorgos Maragkakis, Dimitra Bitchava, Polychronis Kostoulas
67 [GO] 2022―Jan―27 Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6 Fanny Ponthieux, Nicolas Dauby, Evelyne Maillart, Jean-François Fils, Julie Smet, Marc Claus, et al. (+4)
68 [GO] 2022―Jan―12 COVID-19: Testing Landscape Post-Infection, -Vaccination, and Future Perspectives Maite Sabalza, Ilana Heckler, Aya Elhage, Iswariya Venkataraman, Brandon Henry
69 [GO] 2022―Jan―10 Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Poonam S. Deshpande, Irene E. Abraham, Anjali Pitamberwale, Radhika H. Dhote
70 [GO] 2021―Dec―22 Generation and Evaluation of Recombinant Baculovirus Coexpressing GP5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus Type 1 Wang Xu, Shouwen Du, Tiyuan Li, Shipin Wu, Ningyi Jin, Linzhu Ren, Chang Li
71 [GO] 2021―Dec―14 Controlling the Burden of COVID-19 by Manipulating Host Metabolism Logan Miller, Engin Berber, Deepak Sumbria, Barry T. Rouse
72 [GO] 2021―Dec―09 Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective Amirhossein Mardi, Sepideh Meidaninikjeh, Sepideh Nikfarjam, Naime Majidi Zolbanin, Reza Jafari
73 [GO] 2021―Dec―09 Correction to: The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses by Ramírez Hernández et al. Viral Immunol. 2021;34(3):165-173. DOI: 10.1089/vim.2020.0174.
74 [GO] 2021―Nov―08 A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19-Recovered Patients Waleed H. Mahallawi, Mohamed H. Fakher, Mohammad A. Alsarani, Rami H. Aljohani, Salah A. AL-Mutabgani, Nadir A. Ibrahim
75 [GO] 2021―Oct―21 Response to Mishra et al. re “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” Martin Krsak, Brian L. Harry, Brent E. Palmer, Carlos Franco-Paredes
76 [GO] 2021―Oct―21 Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al. Bijaya Kumar Mishra, Debdutta Bhattacharya, Jaya Singh Kshatri, Sanghamitra Pati
77 [GO] 2021―Sep―17 Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients Faezeh Maghsood, Danesh Hassani, Vahid Salimi, Gholam Ali Kardar, Jalal Khoshnoodi, Abbas Ghaderi, et al. (+8)
78 [GO] 2021―Sep―16 Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19 Carlos Jiménez-Cortegana, Julia Liró, Natalia Palazón-Carrión, Elena Salamanca, Jesús Sojo-Dorado, Luis de la Cruz-Merino, et al. (+3)
79 [GO] 2021―Sep―07 Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al. [Epub ahead of print]; DOI: 10.1089/vim.2021.0054 Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
80 [GO] 2021―Sep―07 Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider? Cosby G. Arnold, Andrew A. Monte, Katherine Littlefield, Alexis Vest, Brent E. Palmer
81 [GO] 2021―Aug―13 Levamisole Therapy in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Athanasios Alexiou, Gaber El-Saber Batiha
82 [GO] 2021―Jul―23 Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages Chenghao Huang
83 [GO] 2021―Jul―06 Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2 Martin Krsak, Brian L. Harry, Brent E. Palmer, Carlos Franco-Paredes
84 [GO] 2021―Jun―11 Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19 Mariana Avendaño-Félix, Luis Antonio Ochoa-Ramírez, Rosalío Ramos-Payán, Maribel Aguilar-Medina, Alfredo Ayala-Ham, Horacio Rendón-Aguilar, et al. (+4)
85 [GO] 2021―Jun―08 An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay Haseeb Ahsan, Jong Kyung Sonn, Young Sup Lee, Salman Ul Islam, Saifullah Khan Khalil
86 [GO] 2021―May―21 CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-19 Mengyuan Yang, Zhiyu Liu, Kai Kang, Kaijiang Yu, Changsong Wang
87 [GO] 2021―May―21 Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets Noha A. Kamel, Lamia M. El Wakeel, Khaled M. Aboshanab
88 [GO] 2021―May―17 Herd Immunity Against COVID-19: More Questions Than Answers Rodney S. Russell
89 [GO] 2021―May―13 Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis Anthony R. Mawson, Ashley M. Croft, Federico Gonzalez-Fernandez
90 [GO] 2021―Apr―27 The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes Lixia Xie, Yuanlan Lin, Yushu Deng, Bin Lei
91 [GO] 2021―Mar―19 Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador Robert Needle, Laura Gilbert, George Zahariadis, Yang Yu, Hedy Dalton-Kenny, Rodney S. Russell, et al. (+4)
92 [GO] 2021―Feb―24 T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications Juan Camilo Sarmiento-Monroy, Rafael Parra-Medina, Edgar Garavito, Adriana Rojas-Villarraga
93 [GO] 2021―Feb―19 The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses Eleazar Ramírez Hernández, Luis Fernando Hernández-Zimbrón, Nayeli Martínez Zúñiga, Juan José Leal-García, Violeta Ignacio Hernández, Luis Eduardo Ucharima-Corona, et al. (+2)
94 [GO] 2021―Jan―22 Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology Ashutosh Kumar, Sujeet Kumar, Ravi K. Narayan, Chiman Kumari, Vikas Pareek, Pranav Prasoon
95 [GO] 2020―Dec―22 How to Understand Herd Immunity in the Context of COVID-19 Minghao Dong, Feng He, Yu Deng
96 [GO] 2020―Dec―02 Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19 Sumeyye Kazancioglu, Fatma Meric Yilmaz, Aliye Bastug, Arzu Sakallı, Bahadır Orkun Ozbay, Cansu Buyuktarakci, et al. (+2)
97 [GO] 2020―Dec―02 COVID-19 Infection: Data Gaps for Diagnostic Laboratory Preparedness and Tasks on Hand Subrata Biswas, Piyali Ghosh, Debjit Chakraborty, Ananya Chatterjee, Shanta Dutta, Malay Kumar Saha
98 [GO] 2020―Nov―17 Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19 Yang Gao, Changsong Wang, Kai Kang, Yahui Peng, Yunpeng Luo, Haitao Liu, et al. (+3)
99 [GO] 2020―Nov―12 Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γ as a Novel Antiviral Approach Against COVID-19 Faisal Rasheed Anjum, Sidra Anam, Ghazanfar Abbas, Muhammad Shahid Mahmood, Sajjad ur Rahman, Mohsan Ullah Goraya, et al. (+5)
100 [GO] 2020―Nov―12 COVID-19: Way Forward With Serosurveillance Without Overemphasizing Neutralizing Antibodies Martin Krsak, Andrés F. Henao-Martínez, Carlos Franco-Paredes
101 [GO] 2020―Nov―04 Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons Abdollah Jafarzadeh, Maryam Nemati, Bhaskar Saha, Yashwant D. Bansode, Sara Jafarzadeh
102 [GO] 2020―Oct―05 Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients Sadegh Safaei, Masoud Karimi-Googheri
103 [GO] 2020―Oct―05 COVID-19: Between Past and Present Areej M. Assaf, Randa N. Haddadin, Amal A. Akour
104 [GO] 2020―Sep―28 Coronavirus Disease 2019 Vaccine Development: An Overview Riyadi Sumirtanurdin, Melisa Intan Barliana
105 [GO] 2020―Aug―28 Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection? Nidhi Maheshwari, Ayush Jain
106 [GO] 2020―Jul―02 Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs Ruiyi Zhang, Yanmei Tang
107 [GO] 2020―Jun―09 Call for Papers: Special Issue on Coronaviruses Rodney Russell
108 [GO] 2020―May―13 Call for Papers: Special Issue on Coronaviruses Rodney Russell
109 [GO] 2020―Apr―29 B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020 Julia L. Hurwitz
110 [GO] 2020―Apr―27 Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis José Valter Joaquim Silva Júnior, Thaísa Regina Rocha Lopes, Pablo Sebastian Britto de Oliveira, Rudi Weiblen, Eduardo Furtado Flores
111 [GO] 2020―Apr―16 Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 Yang Liu, Wenjian Liao, Lagen Wan, Tianxing Xiang, Wei Zhang
112 [GO] 2020―Apr―14 Peter's Paradigm and Pandemic Preparedness Maryna C. Eichelberger
113 [GO] 2020―Apr―06 Call for Papers: Special Issue on Coronaviruses
 [1] 

113 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec